Back
BioMarin Pharmaceutical, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$60.15
Seasonality Move:
-2.09%
7 Day Trial
ALL ACCESS PASS
$
7
BioMarin Pharmaceutical, Inc. Stock Forecast
-
Over the next 52 weeks, BioMarin Pharmaceutical, Inc. has on average historically risen by 11.2% based on the past 26 years of stock performance.
-
BioMarin Pharmaceutical, Inc. has risen higher in 14 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%
-
Is BioMarin Pharmaceutical, Inc. Stock Undervalued?The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $59.87. The Score for BMRN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will BioMarin Pharmaceutical, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, BioMarin Pharmaceutical, Inc. has on average historically risen by 11.2% based on the past 26 years of stock performance.
BioMarin Pharmaceutical, Inc. Stock Rating
Sell
40
BioMarin Pharmaceutical, Inc. (BMRN)
is a Sell
Is BioMarin Pharmaceutical, Inc. overpriced?
-
BioMarin Pharmaceutical, Inc. has risen higher in 14 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%
BioMarin Pharmaceutical, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com
52-Week Data
52-Week High:
73.51
52-Week Low:
50.76
Prediction Charts
Market Cap:
11.5B
Price in USD:
59.87
Volume:
1.9M
Beta:
0.84
Technical Analysis
SMA50:
56.90
SMA100:
55.35
SMA200:
56.55
52-Wk Change:
-7.06%
Stock Predictions
-
Is BioMarin Pharmaceutical, Inc. stock public?Yes, BioMarin Pharmaceutical, Inc. is a publicly traded company.
-
What is the BioMarin Pharmaceutical, Inc. stock quote today?The BioMarin Pharmaceutical, Inc. stock price is 59.87 USD today.
-
How to buy BioMarin Pharmaceutical, Inc. stock online?You can buy BioMarin Pharmaceutical, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-27 | 56.60 | 56.85 | 57.15 | 56.16 |
| Jan-28 | 56.73 | 56.68 | 57.33 | 56.01 |
| Jan-29 | 56.27 | 56.99 | 57.04 | 55.80 |
| Jan-30 | 56.36 | 56.54 | 56.98 | 55.28 |
| Feb-2 | 56.40 | 57.95 | 58.50 | 56.26 |
| Feb-3 | 57.15 | 57.61 | 58.76 | 57.10 |
| Feb-4 | 57.84 | 57.62 | 58.26 | 57.03 |
| Feb-5 | 57.69 | 57.15 | 58.29 | 56.87 |
| Feb-6 | 57.26 | 58.13 | 58.43 | 57.26 |
| Feb-9 | 58.13 | 57.81 | 58.15 | 57.32 |
| Feb-10 | 58.00 | 59.66 | 60.75 | 57.90 |
| Feb-11 | 59.43 | 60.31 | 60.79 | 58.62 |
| Feb-12 | 58.39 | 59.94 | 61.48 | 57.84 |
| Feb-13 | 59.94 | 59.87 | 60.99 | 59.45 |
BioMarin Pharmaceutical, Inc. Earnings
BioMarin Pharmaceutical, Inc. Earnings Report: Per Share BioMarin Pharmaceutical, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
BioMarin Pharmaceutical, Inc. Forecast Revenue Growth
BioMarin Pharmaceutical, Inc. Stock Analysis: Historical quarterly revenues per share for BioMarin Pharmaceutical, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $0.85 per share.
* BioMarin Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.